Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and United Therapeutics (UTHR). But which of these two stocks presents ...

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...

Catalyst Pharmaceutical (CPRX) reported $149.39 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 5.6%. EPS of $0.79 for the same period compares to $0.68 ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best biotech stocks with high potential. HC Wainwright reiterated a Buy rating on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) on September ...

Fintel reports that on May 8, 2026, Citigroup downgraded their outlook for Catalyst Pharmaceuticals (NasdaqCM:CPRX) from Buy ...

Renaissance Investment Management, an investment management company, released its Q4 2024 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The Russell 2000 ...

Catalyst Pharmaceuticals' Q1 2026 revenue surged as Firdapse and Agamree drove growth; Angelini’s $31.50 offer limits upside.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...